First-in-human Study of Oral TP-0184 in Patients With Advanced Solid Tumors
Clinical trial NCT03429218 · COMPLETED
Trial details
- NCT number
- NCT03429218
- Sponsor
- Sumitomo Pharma America, Inc.
- Status
- COMPLETED
- Phase
- Phase 1
- Study type
- INTERVENTIONAL
- Start date
- 2018-07-10
- Primary completion
- 2021-03-08
- Enrollment
- 24
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.